{"id":24415,"date":"2025-04-13T17:41:41","date_gmt":"2025-04-13T17:41:41","guid":{"rendered":"https:\/\/globalsourcechemicals.com\/?post_type=product&p=24415"},"modified":"2025-10-02T17:22:23","modified_gmt":"2025-10-02T17:22:23","slug":"pro-lad-175-mcg-blottery","status":"publish","type":"product","link":"https:\/\/globalsourcechemicals.com\/pl\/sklep\/lizergamidy\/pro-lad-175-mcg-blottery\/","title":{"rendered":"Bibu\u0142ki PRO-LAD 175 MCG"},"content":{"rendered":"

PRO-LAD 175mcg Blotters \u2013 Precision Lysergamide for Scientific Research<\/span><\/span><\/strong><\/p>\n

Opis produktu<\/span><\/span><\/strong><\/h3>\n

Nasz\u00a0 <\/span><\/span>Blottery PRO-LAD 175mcg<\/span><\/span><\/strong> \u00a0zaoferowa\u0107\u00a0 <\/span><\/span>precisely dosed,<\/span><\/span><\/strong> \u00a0research-grade form of this rare lysergamide derivative. Each high-quality blotter contains exactly\u00a0 <\/span><\/span>175 micrograms of (6-propyl-nor-lysergamide diethylamide)<\/span><\/span><\/strong> , optimized for\u00a0 <\/span><\/span>controlled scientific research<\/span><\/span><\/strong> .<\/span><\/span><\/p>\n

\u2714\u00a0Perforated blotters<\/span><\/span><\/strong> \u00a0for easy quartering <\/span><\/span>
\n\u2714\u00a0Sublingual absorption<\/span><\/span><\/strong> \u00a0for rapid uptake <\/span><\/span>
\n\u2714\u00a0Neutralny smak<\/span><\/span><\/strong> \u00a0for animal testing convenience <\/span><\/span>
\n\u2714\u00a0Testowane przez osoby trzecie<\/span><\/span><\/strong> \u00a0dla czysto\u015bci i dawkowania<\/span><\/span><\/p>\n

\n

Podsumowanie raportu laboratoryjnego (COA)<\/span><\/span><\/strong><\/h2>\n

*Batch #PROLAD-0127-NL | Tested by LysergiScience Labs* <\/span><\/span>
\n\u2714\u00a0176mcg \u00b12mcg na bibu\u0142\u0119<\/span><\/span><\/strong> \u00a0(HPLC-FLD) <\/span><\/span>
\n\u2714\u00a0Czysto\u015b\u0107 chemiczna 99,0% <\/span><\/span><\/strong>
\n\u2714\u00a0No LSD-25 detectable<\/span><\/span><\/strong> \u00a0(<0,1%) <\/span><\/span>
\n\u2714\u00a0Mikrobiologicznie bezpieczny<\/span><\/span><\/strong> \u00a0(USP <61>)<\/span><\/span><\/p>\n

\n

Zalecane zastosowania badawcze<\/span><\/span><\/strong><\/h2>\n

1. Badanie neuropsychiatryczne<\/span><\/span><\/strong><\/h3>\n